Dr Markita Bobo, PHARMD | |
60 Springfield St, Agawam, MA 01001-1522 | |
(413) 786-1126 | |
Not Available |
Full Name | Dr Markita Bobo |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 60 Springfield St, Agawam, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013291699 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PH232488 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Markita Bobo, PHARMD 60 Springfield St, Agawam, MA 01001-1522 Ph: (413) 786-1126 | Dr Markita Bobo, PHARMD 60 Springfield St, Agawam, MA 01001-1522 Ph: (413) 786-1126 |
News Archive
Giving up smoking is associated with an average weight gain of 4-5 kg after 12 months, most of which occurs within the first three months of quitting, finds a study published on bmj.com today.
Researchers at the Ontario Institute for Cancer Research and University Health Network in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.
Researchers at King's College London and Imperial College London have discovered that people with fewer copies of a gene coding for a carb-digesting enzyme may be at higher risk of obesity. The findings, published in Nature Genetics, suggest that dietary advice may need to be more tailored to an individual's digestive system, based on whether they have the genetic predisposition and necessary enzymes to digest different foods.
In the first experiment of its kind, investigators at the Center for Cancer Nanotechnology Excellence Focused on Therapy Response (CCNE-TR), based at Stanford University, have shown that single-walled carbon nanotubes (SWCNTs) wrapped in poly(ethylene glycol), or PEG, can successfully target tumors in living animals.
AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.
› Verified 6 days ago
Dr. Alexandria Marisa Ferreira, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 163 Silver St, Agawam, MA 01001 Phone: 413-789-3339 | |
Ms. Nicole Marie Benoit, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 Springfield St, Agawam, MA 01001 Phone: 413-786-1126 | |
Ms. Pamela Glemboski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17 Springfield St, Agawam, MA 01001 Phone: 413-786-6060 Fax: 413-789-3368 | |
Carli Sonsini, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 163 Silver St, Agawam, MA 01001 Phone: 413-789-3339 | |
Trathao Trinh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 Springfield St, Agawam, MA 01001 Phone: 413-786-1126 | |
Mr. Donald Carl Bjorklund, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17 Springfield St, Agawam, MA 01001 Phone: 413-786-6060 Fax: 413-789-3368 |